argenx Jobs

Belgium - Zwijnaarde

Biotechnology

argenx is a life sciences company focused on Antibody therapies.

84 open positions at argenx

View Full Profile

Denver

$140K - $193K

Full-time

Director, Regulatory Affairs

argenx

Posted 5d ago

Remote

$212K - $292K

Full-time

VYVGART

Neonatal Presentation (First 28 Days of Life)

RemoteRegulatory AffairsImmunologyExecutive

H-1B · 1 FY23

Associate Director, Regulatory Affairs

argenx

Posted 5d ago

Remote

$164K - $226K

Full-time

VYVGART

Neonatal Presentation (First 28 Days of Life)

RemoteRegulatory AffairsImmunologyExecutive

H-1B · 1 FY23

Medical Affairs and Evidence Generation Asset Lead – Executive Director

argenx

Posted 5d ago

Remote

$175K - $377K

Full-time

VYVGART

Neonatal Presentation (First 28 Days of Life)

RemoteMedical AffairsImmunologyExecutive

H-1B · 1 FY23

Head of Health Economics & Outcomes Research (HEOR)

argenx

Posted 1w ago

Remote

$328K - $451K

Full-time

VYVGART

Neonatal Presentation (First 28 Days of Life)

RemoteReal-World EvidenceImmunologyExecutive

H-1B · 1 FY23

Global Medical Safety Lead

argenx

Posted 1w ago

Remote

Full-time

VYVGART

Neonatal Presentation (First 28 Days of Life)

RemoteImmunologySenior

H-1B · 1 FY23

FB102 Commercial Lead

argenx

Posted 1w ago

Remote

$152K - $287K

Full-time

VYVGART

Neonatal Presentation (First 28 Days of Life)

RemoteCommercialImmunologySenior

H-1B · 1 FY23

Head of Commercial Analytics & Insights

argenx

Posted 1w ago

Remote

$236K - $325K

Full-time

VYVGART

Neonatal Presentation (First 28 Days of Life)

RemoteCommercialImmunologyExecutive

H-1B · 1 FY23

Head of Data Strategy

argenx

Posted 1w ago

Remote

$236K - $325K

Full-time

VYVGART

Neonatal Presentation (First 28 Days of Life)

RemoteBusiness DevelopmentImmunologyExecutive

H-1B · 1 FY23

Associate Director, US Patient Advocacy

argenx

Posted 1w ago

Remote

$164K - $226K

Full-time

VYVGART

Neonatal Presentation (First 28 Days of Life)

RemoteImmunologyExecutive

H-1B · 1 FY23

Senior Director, Commercialization Strategy & Operations Enablement

argenx

Posted 2w ago

Boston, MA, USA

$236K - $325K

Full-time

VYVGART

Neonatal Presentation (First 28 Days of Life)

Business DevelopmentImmunologyExecutive

H-1B · 1 FY23

Head of US Field Reimbursement, West

argenx

Posted 2w ago

United States - Field

$240K - $330K

Full-time

VYVGART

Neonatal Presentation (First 28 Days of Life)

OncologyExecutive

H-1B · 1 FY23

Project Toxicologist

argenx

Posted 2w ago

Gent, Belgium

Full-time

VYVGART

Neonatal Presentation (First 28 Days of Life)

ImmunologyMID

H-1B · 1 FY23

Associate Director Ethics & Compliance

argenx

Posted 2w ago

Remote

Full-time

VYVGART

Neonatal Presentation (First 28 Days of Life)

RemoteLegalImmunologyExecutive

H-1B · 1 FY23

Global DT Lead Development

argenx

Posted 3w ago

Remote

Full-time

VYVGART

Neonatal Presentation (First 28 Days of Life)

RemoteImmunologySenior

H-1B · 1 FY23

Company Overview

Active Jobs

Pipeline Programs

Drug Products

Clinical Trials

View Full Company Profile

Therapeutic Areas

Neurology Immunology Oncology

argenx Jobs

Territory Business Manager - Denver, CO

Director, Regulatory Affairs

Associate Director, Regulatory Affairs

Medical Affairs and Evidence Generation Asset Lead – Executive Director

Medical Affairs and Evidence Generation Asset Lead –Executive Director

Associate Director, Ethics & Compliance - Risk Assessment and Monitoring

Head of Health Economics & Outcomes Research (HEOR)

Global Medical Safety Lead

FB102 Commercial Lead

Head of Commercial Analytics & Insights

Head of Data Strategy

Associate Director, US Patient Advocacy

Associate Director, Statistical Modeling and Simulation

Senior Director, Commercialization Strategy & Operations Enablement

Field Clinical Educator, Pacific Northwest

Executive Director, US HCP Marketing - CIDP Indication Lead

Head of US Field Reimbursement, West

Project Toxicologist

Associate Director Ethics & Compliance

Global DT Lead Development

Company Overview

Therapeutic Areas

Links